Expanding role of lenalidomide in hematologic malignancies by Ghosh N, Grunwald MR, Fasan O, Bhutani M

Get full text

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML by Knapper, S, Russell, N, Gilkes, A, Hills, RK, Gale, RE, Cavenagh, JD, Jones, G, Kjeldsen, L, Grunwald, MR, Thomas, I, Konig, H, Levis, MJ, Burnett, AK